Beschreibung
SAY HELLO TO 1BP-LSD, Our latest legal LSD Microdose.
All our Products are not intended for in-vivo experimentation! Please be careful and make sure to check out our educational Area to inform yourself. We will update this area about Safer
use, legal status and other related topics!
—
WAS IST EINE MIKRODOSIS?
A Microdose is a small pill containing a precise, sub-perceptual amount of a lysergamide.
In this case: 15 µg of 1BP-LSD, produced with accuracy, documentation, and care.
Microdoses allow researchers and educators to work with consistent, reproducible samples — essential for meaningful laboratory analysis.
10 µg is the recommended dosage for regular microdosing protocols. Please check out our Microdosing guide in our Educational Area!
—
WHAT IS 1BP-LSD?
1BP-LSD 1-(3-(tetramethyldioxaborolane)propionyl)-lysergic acid diethylamide is our New Legal LSD Derivative.
It is very similar to LSD due to its Structure and is classified as a direct Prodrug to LSD.
—
1BP-LSD VS. 1S-LSD — WHAT’S THE DIFFERENCE?
Both compounds belong to the family of LSD prodrugs — molecules that convert into LSD under specific metabolic conditions.
1S-LSD
An established legal analogue known for:
• clean, balanced analytical properties
• predictable behavior in laboratory environments
• a well-documented structural profile
1BP-LSD
The newer successor, featuring a fine-tuned structural modification that makes it legally distinct yet functionally comparable within analytical frameworks.
Early laboratory reports indicate:
• greater stability
• longer shelf life
• more consistent results
• Metabolism around 2h
Two molecules, one shared lineage — but each with its own chemical personality.
—
WAS IST EIN PRODRUG?
Think of a prodrug as a key with a protective cap.
The key (LSD) only becomes accessible once the protective group has been removed during a specific metabolic or chemical process.
This family includes:
• 1S-LSD
• 1B-LSD
• 1cP-LSD
• 1SB-LSD
All structurally related, all scientifically intriguing — each offering a unique lens for exploring lysergamide chemistry.
—
MICRODOSING: 1S-LSD VS. 1BP-LSD
While both compounds are appreciated in research environments for their clarity and precision, early comparative analysis often highlights:
• smoother onset during lab simulations
• Metabolism takes a little longer (<2h)
• slightly longer analytical windows
• increased molecular stability during storage
Subjective distinctions remain minimal, but small molecular variations can offer valuable insights in research contexts.
—
WICHTIGE INFORMATIONEN
FairLSD products are:
• Not intended for human consumption
• Not designed for in-vivo use
• Sold strictly for educational, analytical, and laboratory purposes
We champion responsible research, transparency, and harm reduction — always.




